Navigation Links
VIVUS Reports 2010 Fourth Quarter and Full-Year Financial Results
Date:2/28/2011

MOUNTAIN VIEW, Calif., Feb. 28, 2011 /PRNewswire/ -- VIVUS, Inc. (Nasdaq: VVUS), a biopharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today reported its highlights and financial results for the fourth quarter and year ended December 31, 2010.

2010 Highlights

  • In the QNEXA investigational drug development program, we successfully completed the two-year SEQUEL study, an extension study in 675 patients from the CONQUER study.  Results were announced in September and showed sustained weight loss of greater than 10% for both doses of QNEXA over two years.

  • In December, we filed the Marketing Authorization Application, or MAA, to the European Medicines Agency, or EMA, in the European Union for QNEXA as a treatment for obesity. Obesity is a global epidemic, with approximately 150 million European adults affected and the prevalence is rising rapidly.

  • In the avanafil investigational drug development program, we completed the two remaining phase 3 studies: in diabetics with erectile dysfunction and the long-term open label safety study.  Both studies met all primary efficacy endpoints. The NDA filing for avanafil is scheduled for Q2 2011.

  • We divested MUSE and the related assets to Meda AB for $22 million and are eligible to receive a $1.5 million milestone based upon future sales of MUSE.  The transaction closed on November 5, 2010. In connection with the sale, all of our loans and long-term notes payable were repaid and our MUSE-related royalty obligations were terminated.

  • Lastly, we ended the year with $139.2 million in cash, cash equivalents and available for sale securities.

  • QNEXA Regulatory Update  On October 28, 2010, we received a Complete Response Letter, or CRL, from the FDA regarding the QNEXA NDA.  The FD
    '/>"/>

    SOURCE VIVUS, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Results From Phase 3 EQUATE Trial of VIVUS Qnexa Highlighted at European Congress on Obesity
    2. VIVUS Initiates Open Label Safety Study of Avanafil for Erectile Dysfunction
    3. Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting
    4. VIVUS Announces Promotion of Peter Tam to President
    5. VIVUS to Present at Lazard Capital Markets Healthcare Conference
    6. VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity
    7. VIVUS to Host Conference Call and Webcast Discussion of Avanafil Phase 3 Results
    8. VIVUS Announces Sale of MUSE Assets to Meda
    9. FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA®
    10. VIVUS Reports Third Quarter and First Nine Months 2010 Financial Results
    11. VIVUS to Present at Two Upcoming Investor Conferences
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... FLINT, Mich. , Dec. 24, 2014  Diplomat ... largest independent specialty pharmacy, is proud to announce ... and quality at Diplomat, will take office as the ... 2015. The formal induction ceremony will take place Feb. ... which will be held at the Renaissance Center in ...
    (Date:12/24/2014)... and LONDON , December 24, ... industry are expected to grow at an average rate ... of value and volume. Hip, knee and spine surgeries ... while in emerging economies they have a lower penetration. ... challenging the use of composites. Non-metallic orthopedic devices have ...
    (Date:12/24/2014)... 2014 Echo Therapeutics, Inc. (NASDAQ: ... on skin permeation, continuous glucose monitoring and associated ... has been appointed Chief Executive Officer effective ... 20 years of experience in the medical device, ... served as Vice President, Business Development, Otsuka Pharmaceuticals as ...
    Breaking Medicine Technology:Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 2Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 3Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 2Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 3Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 2Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 3
    ... 2011 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP ... and biotechnology research and development outsourcing company, today announced ... shareholders held in Hong Kong today. ... proposed by the Company: 1. THAT ...
    ... Masimo (NASDAQ: MASI ) announced today that ... October 1, 2011, after the market closes on October 25, 2011. ... p.m. PT (4:30 p.m. ET) and will be hosted by Joe ... Executive Vice President and Chief Financial Officer. A live ...
    Cached Medicine Technology:ShangPharma Corporation Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting 2Masimo to Report Third Quarter 2011 Financial Results After Market Close on October 25, 2011 2Masimo to Report Third Quarter 2011 Financial Results After Market Close on October 25, 2011 3
    (Date:12/25/2014)... 26, 2014 “Every three months the trends ... A-line sweetheart evening dress will be one of the hottest ... of Yunx.co.uk says. Today, the company releases 26 A-line sweetheart ... to 80% off. , “We are trying our best ... with our latest designs. Along with affordable prices, we provide ...
    (Date:12/25/2014)... Angeles, CA (PRWEB) December 25, 2014 The ... Dolcemaschio was created in honor of a true 9/11 ... at two film festivals including the 24 hours of Nuremberg ... Festival in Bangladesh. , Actress, screenwriter and director ... helped produce this film together with her husband, Gregory ...
    (Date:12/25/2014)... Woodland Hills, California (PRWEB) December 25, 2014 ... in her home in Woodland Hills, California after an ... Harris passed away on Christmas Eve evening in her ... battle with aggressive metastatic breast cancer. ... International for over forty years, she pioneered and championed ...
    (Date:12/25/2014)... Dennis Thompson HealthDay Reporter ... with complex chronic illnesses can receive effective, less expensive care ... easy access to a team of dedicated health care professionals, ... become seriously ill and need either hospitalization or a trip ... enhanced medical home clinic at the University of Texas in ...
    (Date:12/25/2014)... News) -- Among early stage breast cancer patients who ... one percent will eventually develop leukemia as a result ... finding comes from a review of more than 20,000 ... it suggests that the risk for developing treatment-related leukemia, ... thought. "The frequency of bone marrow cancers such ...
    Breaking Medicine News(10 mins):Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3
    ... A new study provides a novel theory for how ... Center researcher Orrin Devinsky, MD, performed an in-depth analysis ... a consistent pattern of injury to the frontal lobe ... deficits caused by these injuries to the right hemisphere, ...
    ... than three-quarters of young violent offenders interviewed in two poverty-stricken ... violent incident, a new study reveals. , About half of ... said they had a close friend who died in a ... violence may lead some inner-city youth to accept violence as ...
    ... & Johnson will host an analyst meeting at 8:30 ... discuss fourth-quarter and full-year 2008 financial results. The meeting ... Chief Executive Officer.Investors and other interested parties may access ... Company,s website at www.investor.jnj.com . , A webcast ...
    ... Born no larger than a ballpoint pen at birth, ... named the 2009 National Ambassador for the March of Dimes, ... Virginia, was born very early at 25 weeks, weighing less ... only a 5 percent chance of survival. During her five-month ...
    ... health care , , TUESDAY, Jan. 13 (HealthDay News) -- ... approach adulthood to ensure they receive proper health care as ... Peter Scal of the University of Minnesota, found only about ... such as obtaining health insurance after coming of age. This ...
    ... 13 Availity, LLC was recognized,as the 2008 ... at the eighth,annual Excellence in Employee Development Awards ... University of North Florida (UNF) Division of ... along with other award winners, at a luncheon ...
    Cached Medicine News:Health News:Delusions associated with consistent pattern of brain injury 2Health News:Delusions associated with consistent pattern of brain injury 3Health News:Study: Most young violent offenders in two NYC neighborhoods have seen someone killed 2Health News:Study: Most young violent offenders in two NYC neighborhoods have seen someone killed 3Health News:Study: Most young violent offenders in two NYC neighborhoods have seen someone killed 4Health News:Micro-Preemie Survives to Become March of Dimes 2009 National Ambassador 2Health News:Micro-Preemie Survives to Become March of Dimes 2009 National Ambassador 3Health News:Availity Achieves Excellence in Blended Learning Award 2
    Auto refractometer....
    A system with integrated pupil camera and 7" examination monitor. An easy to use configuration....
    ... The Selecta II Glaucoma Laser System features ... patients with open-angle glaucoma. It selectively targets ... intraocular pressure. The Selecta II is equipped ... high-energy beam of light, which induces the ...
    Round handle....
    Medicine Products: